PHRM.L Regulatory News (PHRM)

24 July 2014

Phorm Corporation Limited

("Phorm" or the "Company")

Result of Annual General Meeting

Phorm (AIM: PHRM), a leading internet personalisation technology company, announces that all of the resolutions put forward at its Annual General Meeting held earlier today, as set out in the formal Notice of Annual General Meeting dated 27 June 2014, were duly approved by shareholders.

Accordingly, the proposed Board changes announced on 27 June 2014 comprising the appointment of Mr Johannes Minho Roth as a Non-Executive Director of the Company in place of Mr Christophe Delorme have now been effected.

-Ends-

For further information please contact:

Phorm Corporation Limited

Andy Croxson (analysts and investors) +44 (0) 203 397 6001

UK Investors

Mirabaud Securities LLP (Broker) +44 20 7321 2508

Jason Woollard

Peter Krens

Strand Hanson Limited (Nominated Adviser) +44 20 7409 3494

James Harris

Matthew Chandler

James Dance

US Investors

Lippert/Heilshorn and Associates (Investor Relations) +1 212 838 3777

John Heilshorn

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's industry leading technology enables its Internet Service Provider ("ISP") partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

For more information, please visit: www.phorm.com